Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Actavis Group PTC ehf., Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Iceland
Aspirin 75mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Oval, white, biconvex tablets, 9.0 × 5.0 mm. |
Each tablet contains 75 mg acetylsalicylic acid.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Blister (PVC/PVdC/Aluminium).
Child resistant blister packs (PVC/PVdC/Al/PET/paper).
Child resistant blister packs (PVC/PE/PVdC/Al/glassine paper).
HDPE tablet container with a PP cap.
HDPE tablet container with a child-resistant PP cap.
Pack sizes:
Blisters: 28, 50, 500 or 1000 tablets.
Tablet containers: 100, 105, 500 or 1000 tablets.
Not all pack sizes may be marketed.
Actavis Group PTC ehf., Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Iceland
PL 30306/0776
07/10/2016
| Drug | Countries | |
|---|---|---|
| ASPIRIN | Germany, Finland, Nigeria, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.